2021
DOI: 10.1016/j.msard.2021.103266
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in the John Cunningham virus VP1 gene could predispose to the development of progressive multifocal leukoencephalopathy in multiple sclerosis patients undergoing treatment with natalizumab

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…Point mutations in VP1 can influence virion binding to cellular glycan receptors and their recognition by polyomavirusspecific antibodies (81). Mutation 186G!C (Lys!Asp) in the VP1 gene could predispose MS patients undergoing treatment with natalizumab to PML (82). A deletion of the C-terminal 10 bp of VP1 is closely linked to lytic infection of granule cell neurons and atrophy in the cerebellum of an HIV/PML patient (83).…”
Section: Caspidsmentioning
confidence: 99%
“…Point mutations in VP1 can influence virion binding to cellular glycan receptors and their recognition by polyomavirusspecific antibodies (81). Mutation 186G!C (Lys!Asp) in the VP1 gene could predispose MS patients undergoing treatment with natalizumab to PML (82). A deletion of the C-terminal 10 bp of VP1 is closely linked to lytic infection of granule cell neurons and atrophy in the cerebellum of an HIV/PML patient (83).…”
Section: Caspidsmentioning
confidence: 99%